Reimbursement For ESRD Drugs To Be Based On Average Acquisition Cost
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Medicare & Medicaid Services will base reimbursement for end-stage renal disease therapies in 2005 on the average acquisition cost